Zymeworks Announces Participation in Upcoming Investor Conference

Author's Avatar
Dec 21, 2022

Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will participate in an upcoming investor conference: